- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 231/24 - One oxygen atom attached in position 3 or 5 with aryl radicals attached to ring nitrogen atoms having sulfone or sulfonic acid radicals in the molecule
Patent holdings for IPC class C07D 231/24
Total number of patents in this class: 21
10-year publication summary
|
2
|
3
|
0
|
4
|
2
|
1
|
2
|
0
|
2
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| BASF SE | 21129 |
4 |
| Hoffmann-La Roche Inc. | 3696 |
2 |
| F. Hoffmann-La Roche AG | 7839 |
1 |
| Genentech, Inc. | 4070 |
1 |
| Allergan, Inc. | 2208 |
1 |
| Arena Pharmaceuticals, Inc. | 353 |
1 |
| Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 742 |
1 |
| Jiangsu Simcere Pharmaceutical Co., Ltd | 125 |
1 |
| Jiangsu Yangnong Chemical Co., Ltd. | 61 |
1 |
| McNEIL-PPC, Inc. | 124 |
1 |
| Medshine Discovery Inc. | 592 |
1 |
| The Noguchi Institute | 23 |
1 |
| Trinapco, Inc. | 19 |
1 |
| Shenyang Sinochem Agrochemicals R&D Co., Ltd. | 105 |
1 |
| Esteve Pharmaceuticals, S.A. | 237 |
1 |
| Simcere Pharmaceutical Co., Ltd. | 37 |
1 |
| Scenic Biotech B.V. | 9 |
1 |
| Other owners | 0 |